Literature DB >> 3257214

The role of the diphtheria toxin receptor in cytosol translocation.

V G Johnson1, D Wilson, L Greenfield, R J Youle.   

Abstract

The role of the receptor in the transport of diphtheria toxin (DT) to the cytosol was examined. A point-mutant form of DT, CRM 107 (CRM represents cross-reacting material), that has an 8,000-fold lower affinity for the DT receptor than native toxin was conjugated to transferrin and monoclonal antibodies specific for the cell-surface receptors T3 and Thy1. Conjugating the binding site-inactivated CRM 107 to new binding moieties reconstituted full toxicity, indistinguishable from native DT linked to the same ligand, indicating that the entry activity of the DT B chain can be fully separated from the receptor binding function. Like DT, the toxin conjugates exhibited a dose-dependent lag period before first-order inactivation of protein synthesis. Inactivation of the binding site of the toxin portion of the conjugate was found to have no effect on the kinetics of protein synthesis inactivation. The receptor used by the toxin determined the length of the lag period relative to the killing rate. Comparing the potency of CRM 107 conjugates with native DT, standardized for receptor occupancy, shows that new receptors can be as or more efficient than the DT receptor in transporting DT to the cytosol. The transferrin-CRM 107 conjugate, unlike native DT, was highly toxic to murine cells. All the data presented are consistent with a model that the DT receptor, other than initiating rapid internalization of the toxin to low pH compartments, is unnecessary for transport of the toxin to the cytosol and that membrane translocation activity is expressed by the DT B subunit independent of the receptor-binding site.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3257214

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  24 in total

1.  In vivo T-cell ablation by a holo-immunotoxin directed at human CD3.

Authors:  D M Neville; J Scharff; K Srinivasachar
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

2.  Glycoprotein Erns of pestiviruses induces apoptosis in lymphocytes of several species.

Authors:  C J Bruschke; M M Hulst; R J Moormann; P A van Rijn; J T van Oirschot
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

3.  Mathematical modeling of mutant transferrin-CRM107 molecular conjugates for cancer therapy.

Authors:  Dennis J Yoon; Kevin Y Chen; André M Lopes; April A Pan; Joseph Shiloach; Anne B Mason; Daniel T Kamei
Journal:  J Theor Biol       Date:  2017-01-06       Impact factor: 2.691

Review 4.  Targeted toxins for glioblastoma multiforme: pre-clinical studies and clinical implementation.

Authors:  Marianela Candolfi; Kurt M Kroeger; Weidong Xiong; Chunyan Liu; Mariana Puntel; Kader Yagiz; Akm Ghulam Muhammad; Yohei Mineharu; David Foulad; Mia Wibowo; Hikmat Assi; Gregory J Baker; Pedro R Lowenstein; Maria G Castro
Journal:  Anticancer Agents Med Chem       Date:  2011-10       Impact factor: 2.505

5.  High-yield production of diphtheria toxin mutants by high-density culture of C7 (beta)tox+ strains grown in a non-deferrated medium.

Authors:  R Fass; S Bahar; J Kaufman; J Shiloach
Journal:  Appl Microbiol Biotechnol       Date:  1995-04       Impact factor: 4.813

6.  Identification of a single amino acid substitution in the diphtheria toxin A chain of CRM 228 responsible for the loss of enzymatic activity.

Authors:  V G Johnson; P J Nicholls
Journal:  J Bacteriol       Date:  1994-08       Impact factor: 3.490

Review 7.  Gene therapy and targeted toxins for glioma.

Authors:  Maria G Castro; Marianela Candolfi; Kurt Kroeger; Gwendalyn D King; James F Curtin; Kader Yagiz; Yohei Mineharu; Hikmat Assi; Mia Wibowo; A K M Ghulam Muhammad; David Foulad; Mariana Puntel; Pedro R Lowenstein
Journal:  Curr Gene Ther       Date:  2011-06       Impact factor: 4.391

8.  Genetically engineering transferrin to improve its in vitro ability to deliver cytotoxins.

Authors:  Dennis J Yoon; David S H Chu; Christopher W Ng; Edward A Pham; Anne B Mason; David M Hudson; Valerie C Smith; Ross T A MacGillivray; Daniel T Kamei
Journal:  J Control Release       Date:  2008-10-21       Impact factor: 9.776

9.  Diphtheria toxin mutant selectively kills cerebellar Purkinje neurons.

Authors:  C J Riedel; K M Muraszko; R J Youle
Journal:  Proc Natl Acad Sci U S A       Date:  1990-07       Impact factor: 11.205

10.  Characterization of macrophage sensitivity and resistance to anthrax lethal toxin.

Authors:  A M Friedlander; R Bhatnagar; S H Leppla; L Johnson; Y Singh
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.